Truemeds (Series B)
Funding Details
Awarder
RSS - techcrunch.com
Date Award
August 10, 2025
Vertical
Biotech and Health
Premoney Valuation
$110,000,000
Valuation
$400,000,000
Funding Amount
$85,000,000
Company Info
Founding Year
2019
Traction
Truemeds has seen revenue growth of over 66% year-over-year, reaching ₹5 billion ($57 million) in the last financial year. It serves an average of 500,000 customers each month, with a total of 3 million customers to date.
Revenue Amount
$57,000,000
Founders
Akshat Nayyar
Market
Healthcare
Location
Mumbai, India
Coinvestors
Accel, Peak XV Partners, WestBridge Capital, InfoEdge Ventures
Company Description

Truemeds is a startup that helps patients switch to lower-cost generic substitutes for branded medicines, focusing on affordability in the Indian healthcare market. It recommends generic alternatives to consumers, helping them save money while serving a large customer base across the country.

Links